within Pharmacolibrary.Drugs.ATC.P;

model P02CF01
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.6,
    Cl             = 1.9999999999999998e-05,
    adminDuration  = 600,
    adminMass      = 12 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0035,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0016666666666666668,
    Tlag           = 60,            
    Vdp             = 0.012,
    k12             = 2.5,
    k21             = 2.5
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>P02CF01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ivermectin is an antiparasitic agent used for the treatment of various parasitic infections, including onchocerciasis (river blindness), strongyloidiasis, and other helminthic infestations. It is also used for scabies and lice infestations. Ivermectin is approved for human use and is included in the WHO List of Essential Medicines.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers (non-pregnant, both sexes), single-dose administration.</p><h4>References</h4><ol><li><p>Johnson-Arbor, K (2022). Ivermectin: a mini-review. <i>Clinical toxicology (Philadelphia, Pa.)</i> 60(5) 571–575. DOI:<a href=\"https://doi.org/10.1080/15563650.2022.2043338\">10.1080/15563650.2022.2043338</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35225114/\">https://pubmed.ncbi.nlm.nih.gov/35225114</a></p></li><li><p>Duthaler, U, et al., &amp; Hammann, F (2020). The effect of food on the pharmacokinetics of oral ivermectin. <i>The Journal of antimicrobial chemotherapy</i> 75(2) 438–440. DOI:<a href=\"https://doi.org/10.1093/jac/dkz466\">10.1093/jac/dkz466</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31691813/\">https://pubmed.ncbi.nlm.nih.gov/31691813</a></p></li><li><p>Sartini, I, et al., &amp; Giorgi, M (2022). Pharmacokinetics of ivermectin after oral and intravenous administration in Biłgorajska geese (. <i>New Zealand veterinary journal</i> 70(6) 313–318. DOI:<a href=\"https://doi.org/10.1080/00480169.2022.2104398\">10.1080/00480169.2022.2104398</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35852416/\">https://pubmed.ncbi.nlm.nih.gov/35852416</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end P02CF01;
